Outcomes of GDPT (gemcitabine, cisplatin, prednisone, thalidomide) CHOP in newly diagnosed peripheral T-cell lymphoma patients

Outcomes of GDPT (gemcitabine, cisplatin, prednisone, thalidomide) CHOP in newly diagnosed peripheral T-cell lymphoma patients

Aim: To compare the outcomes of GDPT [gemcitabine (G), cisplatin (D), prednisone (P), thalidomide (T)] versus CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone) in treating newly diagnosed PTCL (peripheral T-cell lymphoma). Methods: An open-label prospective clinical trial with 153 newly...

Full description

Bibliographic Details
Main Authors: Yuanyuan Sun, Ling Li, Xin Li, Lei Zhang, Xinhua Wang, Xiaorui Fu, Zhenchang Sun, Xudong Zhang, Zhaoming Li, Jingjing Wu, Hui Yu, Yu Chang, Jiaqin Yan, Xiaolong Wu, Zhiyuan Zhou, Feifei Nan, Li Tian, Mingzhi Zhang
Format: Article
Language:English
Published: SAGE Publishing 2020-05-01
Series:Therapeutic Advances in Medical Oncology
Online Access:https://doi.org/10.1177/1758835920923829

Internet

https://doi.org/10.1177/1758835920923829

Similar Items